John Kenneth Jenkins, Director at Corbus Pharmaceuticals Holdings, Inc. (CRBP), sold 2,783 shares at $7.35 ($20K) on 2025-05-30, disclosed to the SEC on 2025-06-02.
Scheduled sale ($20k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |